Literature DB >> 10770980

Lack of effect of a high-fiber cereal supplement on the recurrence of colorectal adenomas. Phoenix Colon Cancer Prevention Physicians' Network.

D S Alberts1, M E Martínez, D J Roe, J M Guillén-Rodríguez, J R Marshall, J B van Leeuwen, M E Reid, C Ritenbaugh, P A Vargas, A B Bhattacharyya, D L Earnest, R E Sampliner.   

Abstract

BACKGROUND: The risks of colorectal cancer and adenoma, the precursor lesion, are believed to be influenced by dietary factors. Epidemiologic evidence that cereal fiber protects against colorectal cancer is equivocal. We conducted a randomized trial to determine whether dietary supplementation with wheat-bran fiber reduces the rate of recurrence of colorectal adenomas.
METHODS: We randomly assigned 1429 men and women who were 40 to 80 years of age and who had had one or more histologically confirmed colorectal adenomas removed within three months before recruitment began to a supervised program of dietary supplementation with either high amounts (13.5 g per day) or low amounts (2 g per day) of wheat-bran fiber. The primary end point was the presence or absence of new adenomas at the time of follow-up colonoscopy. Subjects and physicians, including colonoscopists, were unaware of the group assignments.
RESULTS: Of the 1303 subjects who completed the study, 719 had been randomly assigned to the high-fiber group and 584 to the low-fiber group. The median times from randomization to the last follow-up colonoscopy were 34 months in the high-fiber group and 36 months in the low-fiber group. By the time of the last follow-up colonoscopy, at least one adenoma had been identified in 338 subjects in the high-fiber group (47.0 percent) and in 299 subjects in the low-fiber group (51.2 percent). The multivariate adjusted odds ratio for recurrent adenoma in tile high-fiber group, as compared with the low-fiber group, was 0.88 (95 percent confidence interval, 0.70 to 1.11; P=0.28), and the relative risk of recurrence according to the number of adenomas, in the high-fiber group as compared with the low-fiber group, was 0.99 (95 percent confidence interval, 0.71 to 1.36; P=0.93).
CONCLUSIONS: As used in this study, a dietary supplement of wheat-bran fiber does not protect against recurrent colorectal adenomas.

Entities:  

Mesh:

Year:  2000        PMID: 10770980     DOI: 10.1056/NEJM200004203421602

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  126 in total

1.  Civilisation and the colon: constipation as the "disease of diseases".

Authors:  J Whorton
Journal:  BMJ       Date:  2000 Dec 23-30

2.  Dietary fibre and the risk of colorectal cancer.

Authors:  R A Goodlad
Journal:  Gut       Date:  2001-05       Impact factor: 23.059

3.  Civilization and the colon. Constipation as "the disease of diseases".

Authors:  J Whorton
Journal:  West J Med       Date:  2000-12

Review 4.  Most effective colon cancer chemopreventive agents in rats: a systematic review of aberrant crypt foci and tumor data, ranked by potency.

Authors:  Denis E Corpet; Sylviane Taché
Journal:  Nutr Cancer       Date:  2002       Impact factor: 2.900

5.  Polymorphic variation in the GC and CASR genes and associations with vitamin D metabolite concentration and metachronous colorectal neoplasia.

Authors:  Elizabeth A Hibler; Chengcheng Hu; Peter W Jurutka; Maria E Martinez; Elizabeth T Jacobs
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-12-05       Impact factor: 4.254

6.  Short chain fatty acids differentially modulate cellular phenotype and c-myc protein levels in primary human nonmalignant and malignant colonocytes.

Authors:  N J Emenaker; M D Basson
Journal:  Dig Dis Sci       Date:  2001-01       Impact factor: 3.199

7.  Diet and colorectal cancer: fibre back on the menu?

Authors:  R P Arasaradnam; S A Riley; B M Corfe
Journal:  Gut       Date:  2004-01       Impact factor: 23.059

Review 8.  Environmental Factors, Gut Microbiota, and Colorectal Cancer Prevention.

Authors:  Mingyang Song; Andrew T Chan
Journal:  Clin Gastroenterol Hepatol       Date:  2018-07-18       Impact factor: 11.382

9.  A pooled analysis of advanced colorectal neoplasia diagnoses after colonoscopic polypectomy.

Authors:  María Elena Martínez; John A Baron; David A Lieberman; Arthur Schatzkin; Elaine Lanza; Sidney J Winawer; Ann G Zauber; Ruiyun Jiang; Dennis J Ahnen; John H Bond; Timothy R Church; Douglas J Robertson; Stephanie A Smith-Warner; Elizabeth T Jacobs; David S Alberts; E Robert Greenberg
Journal:  Gastroenterology       Date:  2008-12-09       Impact factor: 22.682

10.  Synergy between docosahexaenoic acid and butyrate elicits p53-independent apoptosis via mitochondrial Ca(2+) accumulation in colonocytes.

Authors:  Satya Sree N Kolar; Rola Barhoumi; Evelyn S Callaway; Yang-Yi Fan; Naisyin Wang; Joanne R Lupton; Robert S Chapkin
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2007-08-23       Impact factor: 4.052

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.